Eagle Bay Advisors’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-63
| Closed | -$7.66K | – | 833 |
|
|
2024
Q4 | $7.66K | Hold |
63
| – | – | ﹤0.01% | 608 |
|
|
2024
Q3 | $7.87K | Hold |
63
| – | – | ﹤0.01% | 847 |
|
|
2024
Q2 | $9.95K | Hold |
63
| – | – | 0.01% | 558 |
|
|
2024
Q1 | $8.16K | Hold |
63
| – | – | 0.01% | 620 |
|
|
2023
Q4 | $6.08K | Hold |
63
| – | – | ﹤0.01% | 602 |
|
|
2023
Q3 | $7.64K | Hold |
63
| – | – | ﹤0.01% | 633 |
|
|
2023
Q2 | $7.22K | Hold |
63
| – | – | ﹤0.01% | 627 |
|
|
2023
Q1 | $8.68K | Hold |
63
| – | – | ﹤0.01% | 609 |
|
|
2022
Q4 | $8.16K | Hold |
63
| – | – | ﹤0.01% | 620 |
|
|
2022
Q3 | $7K | Hold |
63
| – | – | ﹤0.01% | 644 |
|
|
2022
Q2 | $4.72K | Buy |
+63
| New | +$4.72K | ﹤0.01% | 714 |
|
|
2022
Q1 | – | Sell |
-63
| Closed | -$6K | – | 865 |
|
|
2021
Q4 | $6K | Hold |
63
| – | – | ﹤0.01% | 749 |
|
|
2021
Q3 | $6K | Hold |
63
| – | – | ﹤0.01% | 775 |
|
|
2021
Q2 | $5K | Buy |
+63
| New | +$5K | ﹤0.01% | 753 |
|